Clinical trial · Interventional
Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma
Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma A Multicenter, Prospective Blinded Study
NCT02647112CI-TRIAL-00051603completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Clinical trial to determine the performance characteristics (sensitivity and specificity) of the Bladder EpiCheck test compared to the gold standard cystoscopy and pathology.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Bladder EpiCheck | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Bladder EpiCheck
- description
- Urine sample will be tested with the Bladder EpiCheck in conjunction with cystoscopy and cytology
- interventionNames
- Other: Bladder EpiCheck
- type
- NO_INTERVENTION
- label
- Practice of medicine
- description
- Practice of medicine including cystoscopy and cytology
Primary outcomes (2)
- measure
- Sensitivity (the proportion of positives that are correctly identified as such by the gold standard)
- timeFrame
- Day 1
- description
- the proportion of positives that are correctly identified as such by the gold standard
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 22 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: * Patient diagnosed with incident or recurrent urothelial cell carcinoma and undergoing surveillance monitoring for urothelial cell carcinoma * Has all urothelial cell carcinoma tumor resected within the past 12 months * Has a plan for cystoscopic surveillance Exclusion Criteria: * Planning to undergo radical cystectomy or chemotherapy-radiation for UCC
References
Publications (0)
Data not yet available
No reference posted for this study.